Safety evaluation and toxicology studies and related services for drug development
Active Awarded
- Contract number
- 75N95024D00023
- Awardee
-
Charles River Laboratories, Inc. UEI NAPSK1UAMAE5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,000 obligated
Award facts
- Opportunity
-
- Safety Evaluation and Toxicology Studies and Related Services for Drug Development Pre-Solicitation · 75N95023R00029 · Posted May 11, 2023
- Combined order value
- $1,000 Current and potential, with all options
- Last date to order 37% complete
- IDV ceiling <1% used
- $48,622,546.00
- Maximum order
- $48,622,546.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030.
Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies on small molecules and biologics to support regulatory filings with the FDA. This includes assays such as mitochondrial toxicity, hemolysis, and genetic toxicology, as well as general toxicology and pharmacology studies in relevant animal models. The work will aid therapeutic target evaluation, lead optimization, and compound selection for NCATS' drug development pipeline. The contract was awarded on a full and open competition basis with no set-asides.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Kick-off meeting for safety evaluation and toxicology studies and related services for drug development | National Institute on Drug Abuse (NIH) | $1,000 |
Quick answers
Who was awarded contract 75N95024D00023?
75N95024D00023 was awarded to Charles River Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 12, 2024.
How much is contract 75N95024D00023 worth?
Orders under 75N95024D00023 have obligated $1,000. 75N95024D00023's own ceiling is $48,622,546. A single order can be worth up to $48,622,546.
How many orders have been placed under contract 75N95024D00023?
1 order has been placed under 75N95024D00023, the latest on August 12, 2024.
Which agency awarded contract 75N95024D00023?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024D00023, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract 75N95024D00023?
75N95024D00023 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00023 part of a contract vehicle?
Yes. 75N95024D00023 is part of Safety Evaluation and Toxicology Studies and Related Services for Drug Development.
Was contract 75N95024D00023 competed?
The extent of competition for 75N95024D00023 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV